Mardi Dier, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,258 shares at $40.16 ($131K) on 2022-10-14, disclosed to the SEC on 2022-10-17.
Open-market sale of $131k RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.16 | 1,629 | $65K | 50.0% |
| 2 | $40.16 | 1,629 | $65K | 50.0% |
| Total | $40.16 avg | 3,258 | $131K | 100% |
| Filing → |
| MDGL | SELL | 2025-12-03 | $3.6M | — | Filing → |
| MDGL | SELL | 2025-03-12 | $167K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $1.3M | — | Filing → |